# Evaluate the Safety and Effectiveness of Using Echogenic Embolic Agent for Embolization of Prostate Artery for Treatment of Men With BPH (PAE CEUS)

> **NCT04267445** · — · UNKNOWN · sponsor: **University of Calgary** · enrollment: 15 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **PROCEDURE:** Embolization of prostatic artery under ultrasound guidance

## Key facts

- **NCT ID:** NCT04267445
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03
- **Primary completion:** 2021-12
- **Final completion:** 2023-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04267445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04267445, "Evaluate the Safety and Effectiveness of Using Echogenic Embolic Agent for Embolization of Prostate Artery for Treatment of Men With BPH (PAE CEUS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04267445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*